The Novartis Access one-year report describes first results, early learnings and challenges from our first twelve months on the ground. It also includes external perspectives and country updates, showcasing the progress we have made as we roll out the program.
The case study, called "Novartis Access: Democratizing Health Care,” looks at the program and its results so far, as well as lessons learned, challenges and outlook for the future.
The event, called “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016, on the Novartis Campus in Basel, Switzerland and will also be webcast.
An editorial by Anthony Gitau, Head of Novartis Access in Kenya
An editorial by Harald Nusser, Head Novartis Access & Malaria Initiative
While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.
An editorial by Harald Nusser, Head Novartis Access & Malaria Initiative, in DEVEX
Novartis Access perspectives: A guest blog on Pharma Views by Anthony Gitau, Head Novartis Access in Kenya
An opinion piece by Dr. Samuel Mwenda published in US News & World Report
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.